Summary

The veterinary parasiticides market is poised for significant expansion, with projections indicating a rise from US$10.42 Bn in 2025 to US$16.78 Bn by 2032. This growth, at a compound annual growth rate (CAGR) of 7.03%, is driven by rising pet care awareness, growing livestock populations, and increasing concerns over parasitic infections in both companion and production animals.

Veterinary parasiticides are pharmaceutical solutions designed to prevent and treat parasitic infections in animals, ranging from internal parasites like worms to external threats like ticks and fleas. Their application is essential for maintaining animal health, improving productivity in livestock, and ensuring food safety.

Market Insights

Veterinary parasiticides remain a vital part of modern animal healthcare, offering effective treatment against a wide range of parasites. These products are becoming more advanced, with new formulations focusing on long-lasting effects, easy application, and combination therapies. The market is witnessing increased investment in research and development to introduce innovative and more sustainable solutions.

The ectoparasiticides segment continues to lead the market due to its effectiveness in treating external parasites and its wide availability in user-friendly forms such as sprays, spot-on treatments, powders, and ointments. These solutions are particularly appealing due to their external application, reducing the risk of systemic side effects and allowing for targeted action.

Growth Drivers

One of the strongest growth drivers is the surge in pet ownership worldwide. As more people consider pets as family members, demand for quality veterinary care, including parasite prevention, is increasing rapidly. Pet owners are more informed than ever and are seeking preventative healthcare solutions that ensure their animals remain healthy and parasite-free.

Simultaneously, the global expansion of the livestock industry is fueling market demand. As the need for animal-based products such as meat, milk, and eggs rises, maintaining livestock health becomes a priority. Parasitic infections can reduce productivity and quality, prompting widespread use of parasiticides in animal husbandry.

Technological progress is another key factor. Recent advances in veterinary medicine have enabled the development of combination products, long-acting medications, and digital monitoring systems that improve the timing and effectiveness of parasite control treatments.

Business Opportunities

The most promising opportunities lie in emerging markets across Asia, Latin America, and Africa. These regions are experiencing rapid economic development, urbanization, and a shift in consumer habits. As incomes rise, so does the demand for both pet care products and safe, quality meat and dairy products.

Emerging economies are also investing in modernizing their veterinary infrastructure and raising awareness around livestock health. This, in turn, creates a favorable environment for the growth of veterinary parasiticides. Companies that tailor their product offerings to suit local parasite strains and price sensitivities will be well-positioned to tap into this growing demand.

In addition, the increasing adoption of pet insurance in developing regions is helping consumers afford regular veterinary care, further boosting demand for parasiticides.

Regional Analysis

North America continues to be a leading market for veterinary parasiticides. Factors such as high pet adoption rates, a strong meat production industry, and robust veterinary healthcare systems contribute to this dominance. Moreover, regulatory efforts to combat antiparasitic resistance—like the American Veterinary Medical Association’s 2022 guidelines—support sustainable use of parasiticides.

Europe follows with a significant market share, aided by stringent animal welfare regulations and a knowledgeable consumer base. Meanwhile, the Asia Pacific region is anticipated to witness the fastest growth due to increasing livestock numbers and growing pet ownership in countries such as China and India.

Latin America and the Middle East & Africa are also emerging as high-potential markets. These regions are focusing on improving their animal health systems and addressing issues like parasitic infections, which can affect both food security and public health.

Key Players

The global veterinary parasiticides market is highly competitive, with key players focusing on strategic expansions, partnerships, and innovation. Leading companies are investing in developing novel products with enhanced efficacy, user-friendliness, and safety profiles.

Notable players include:

• Zoetis

• Boehringer Ingelheim

• Merck & Co., Inc.

• Elanco Animal Health

• Dechra Pharmaceuticals Plc.

• Ceva Sante Animale

• Virbac

• Biogénesis Bagó

• Vetoquinol

• Himalaya Wellness

These companies are at the forefront of developing targeted parasiticides for both companion animals and livestock. For example, in May 2024, Petmedica introduced Atrevia 360, a chewable parasiticide for dogs that offers three-month protection against fleas, ticks, and mites, along with monthly protection against internal parasites.

Challenges and Restraints

Despite a promising outlook, the veterinary parasiticides market faces several challenges. The stringent regulatory frameworks across different regions often delay product approvals and increase costs for manufacturers. Regulatory compliance can be especially burdensome for smaller companies attempting to enter the market or expand globally.

Another critical issue is the growing resistance among parasites to existing treatments. Overuse or misuse of parasiticides can lead to decreased efficacy, forcing producers to develop new formulations and treatment strategies. This drives up research and development costs and may reduce consumer trust if not managed properly.

Future Outlook

Looking ahead, the veterinary parasiticides market is expected to maintain its momentum through continuous innovation and growing awareness. Increasing demand for animal protein, coupled with enhanced pet care expenditure, will continue to support the industry’s upward trajectory.

Developing cost-effective, long-lasting, and eco-friendly solutions will be key to addressing future challenges such as parasite resistance and regulatory compliance. Integration of technologies like smart sensors and real-time monitoring tools into parasite management systems will open up new avenues for product development.

Companies that focus on localizing their products for emerging markets, offering affordable options, and complying with regional regulatory demands will be well-positioned for long-term success.

Market Segmentation

By Animal Type:

• Production Animal

• Companion Animal

By Product:

• Ectoparasiticides

• Endoparasiticides

• Endectocides

By Route of Administration:

• Oral

• Injectable

• Topical

By Region:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Veterinary Parasiticides Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. PESTLE Analysis
3. Global Veterinary Parasiticides Market Outlook, 2019-2032
3.1. Global Veterinary Parasiticides Market Outlook by Animal Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Production Animal
3.1.1.2. Companion Animal
3.2. Global Veterinary Parasiticides Market Outlook by Product, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Ectoparasiticides
3.2.1.2. Endoparasiticides
3.2.1.3. Endectocides
3.3. Global Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Oral
3.3.1.2. Injectable
3.3.1.3. Topical
3.4. Global Veterinary Parasiticides Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Veterinary Parasiticides Market Outlook, 2019-2032
4.1. North America Veterinary Parasiticides Market Outlook, by Animal Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Production Animal
4.1.1.2. Companion Animal
4.2. North America Veterinary Parasiticides Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Ectoparasiticides
4.2.1.2. Endoparasiticides
4.2.1.3. Endectocides
4.3. North America Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Oral
4.3.1.2. Injectable
4.3.1.3. Topical
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Veterinary Parasiticides Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Veterinary Parasiticides Market Outlook, 2019-2032
5.1. Europe Veterinary Parasiticides Market Outlook, by Animal Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Production Animal
5.1.1.2. Companion Animal
5.2. Europe Veterinary Parasiticides Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Ectoparasiticides
5.2.1.2. Endoparasiticides
5.2.1.3. Endectocides
5.3. Europe Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Oral
5.3.1.2. Injectable
5.3.1.3. Topical
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Veterinary Parasiticides Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.7. France Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.8. France Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.9. France Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Veterinary Parasiticides Market Outlook, 2019-2032
6.1. Asia Pacific Veterinary Parasiticides Market Outlook, by Animal Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Production Animal
6.1.1.2. Companion Animal
6.2. Asia Pacific Veterinary Parasiticides Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Ectoparasiticides
6.2.1.2. Endoparasiticides
6.2.1.3. Endectocides
6.3. Asia Pacific Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Oral
6.3.1.2. Injectable
6.3.1.3. Topical
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Veterinary Parasiticides Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.2. China Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.3. China Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.1.10. India Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.11. India Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.12. India Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Veterinary Parasiticides Market Outlook, 2019-2032
7.1. Latin America Veterinary Parasiticides Market Outlook, by Animal Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Production Animal
7.1.1.2. Companion Animal
7.2. Latin America Veterinary Parasiticides Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.2.1.1. Ectoparasiticides
7.2.1.2. Endoparasiticides
7.2.1.3. Endectocides
7.3. Latin America Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Oral
7.3.1.2. Injectable
7.3.1.3. Topical
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Veterinary Parasiticides Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Veterinary Parasiticides Market Outlook, 2019-2032
8.1. Middle East & Africa Veterinary Parasiticides Market Outlook by Animal Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Production Animal
8.1.1.2. Companion Animal
8.2. Middle East & Africa Veterinary Parasiticides Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Ectoparasiticides
8.2.1.2. Endoparasiticides
8.2.1.3. Endectocides
8.3. Middle East & Africa Veterinary Parasiticides Market Outlook, by Route of Administration, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Oral
8.3.1.2. Injectable
8.3.1.3. Topical
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Veterinary Parasiticides Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Veterinary Parasiticides Market by Animal Type, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Veterinary Parasiticides Market by Product, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Veterinary Parasiticides Market by Route of Administration, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Zoetis
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Boehringer Ingelheim
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Merck & Co. Inc.
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Dechra Pharmaceuticals Plc.
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Elanco Animal Health
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Ceva Sante Animale
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Virbac
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Biogénesis Bagó
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Others
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations